pharmaceuticals
pharmaceuticals Articles
For more than half a decade, the United States has seen an incredible rise of an opioid epidemic within its borders. According to a recent study, drug makers and federal regulators are the ones to...
Published:
Last Updated:
On Wednesday, Johnson & Johnson announced that a subsidiary had entered a definitive agreement to acquire a robotic technology firm focused on lung cancer.
Published:
Last Updated:
Teva released mixed fourth-quarter financial results before the markets opened on Wednesday and its shares pulled back.
Published:
Last Updated:
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
Published:
Last Updated:
Merck released better-than-expected fourth-quarter financial results after the markets closed on Thursday.
Published:
Last Updated:
Merck is scheduled to release its fourth-quarter before the markets open on Friday, and analysts are looking for solid top and bottom line growth.
Published:
Last Updated:
The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies post quarterly results that beat top-line Wall Street expectations.
Published:
Last Updated:
More and more branded drugs seem to be facing generic competition. The impact might not be so positive for Big Pharma giants, but this can be a serious victory for consumers and patients who are in...
Published:
Last Updated:
There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options for devices,...
Published:
Last Updated:
Pfizer released better-than-expected fourth-quarter financial results and guidance before the markets opened on Tuesday.
Published:
Last Updated:
Pfizer is scheduled to release its fourth-quarter financial results before the markets open on Tuesday. Consensus estimates call for modest year-over-year growth.
Published:
Last Updated:
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
AbbVie shares retreated after it released disappointing fourth-quarter financial results before the markets opened on Friday.
Published:
Last Updated:
Bristol-Myers Squibb reported better-than-expected quarterly results before the markets opened on Thursday.
Published:
Last Updated: